data

Vodafone and Cyient unveil AI-Powered Network Configuration Management Solution to deliver Data driven, Smarter Network OperationsVodafone and Cyient unveil AI-Powered Network Configuration Management Solution to deliver Data driven, Smarter Network Operations

Vodafone and Cyient unveil AI-Powered Network Configuration Management Solution to deliver Data driven, Smarter Network Operations

HYDERABAD, India and DALLAS, June 24, 2025 /PRNewswire/ -- In a landmark collaboration, Vodafone, a leading technology communications company and Cyient,…

3 weeks ago
Actian Embeds Data Contracts, Governance by Design into Development Workflows to Increase Data ReliabilityActian Embeds Data Contracts, Governance by Design into Development Workflows to Increase Data Reliability

Actian Embeds Data Contracts, Governance by Design into Development Workflows to Increase Data Reliability

Actian's "data contract first" principle enables full visibility and control over distributed data assets, from creation to consumption  ROUND ROCK,…

3 weeks ago
Chunghwa Telecom Receives Frost & Sullivan’s 2025 Taiwan Competitive Strategy Leadership Award for Excellence in Data Center ServicesChunghwa Telecom Receives Frost & Sullivan’s 2025 Taiwan Competitive Strategy Leadership Award for Excellence in Data Center Services

Chunghwa Telecom Receives Frost & Sullivan’s 2025 Taiwan Competitive Strategy Leadership Award for Excellence in Data Center Services

The company is recognized for driving AI-ready infrastructure, strategic innovation, and sustainable growth in Taiwan's fast-evolving data center market. SAN…

3 weeks ago
Aon Launches Aon Broker Copilot to Modernize Insurance Placement with AI and Data at ScaleAon Launches Aon Broker Copilot to Modernize Insurance Placement with AI and Data at Scale

Aon Launches Aon Broker Copilot to Modernize Insurance Placement with AI and Data at Scale

Firm is undertaking one of the most ambitious digital transformations across the broker universe DUBLIN, June 23, 2025 /PRNewswire/ -- Aon…

3 weeks ago
Novo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data presented at the ISTH 2025 CongressNovo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data presented at the ISTH 2025 Congress

Novo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data presented at the ISTH 2025 Congress

New FRONTIER5 data show that a direct switch to investigational Mim8 (denecimig) prophylaxis treatment from emicizumab, without the need for…

4 weeks ago
BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific SessionsBioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

June 21, 2025 18:00 ET  | Source: BioAge Labs, Inc. Treatment with apelin receptor agonist enhanced glycemic control and demonstrated…

4 weeks ago
Abvance Therapeutics Announces Presentation of Human Clinical Data at the 85th Scientific Sessions of the American Diabetes AssociationAbvance Therapeutics Announces Presentation of Human Clinical Data at the 85th Scientific Sessions of the American Diabetes Association

Abvance Therapeutics Announces Presentation of Human Clinical Data at the 85th Scientific Sessions of the American Diabetes Association

CHICAGO, June 21, 2025 (GLOBE NEWSWIRE) -- Abvance Therapeutics, a biotechnology company developing next generation glucagon analogs and therapies to…

4 weeks ago
Actuate Therapeutics Reports Positive Biomarker and Machine Learning Data from Phase 2 Elraglusib Trial in First-Line Treatment of Metastatic Pancreatic Cancer at ASCOActuate Therapeutics Reports Positive Biomarker and Machine Learning Data from Phase 2 Elraglusib Trial in First-Line Treatment of Metastatic Pancreatic Cancer at ASCO

Actuate Therapeutics Reports Positive Biomarker and Machine Learning Data from Phase 2 Elraglusib Trial in First-Line Treatment of Metastatic Pancreatic Cancer at ASCO

Phase 2 highlights robust biomarker identification and survival correlations in first-line metastatic pancreatic cancer (mPDAC) treated with elraglusib June 20,…

4 weeks ago
Oper8 Global Group Receives Frost & Sullivan’s 2025 European Customer Value Leadership Recognition for Excellence in Edge Data Center SolutionsOper8 Global Group Receives Frost & Sullivan’s 2025 European Customer Value Leadership Recognition for Excellence in Edge Data Center Solutions

Oper8 Global Group Receives Frost & Sullivan’s 2025 European Customer Value Leadership Recognition for Excellence in Edge Data Center Solutions

This award recognizes Oper8 Global Group's innovation in edge data center for artificial intelligence and high-performance computing, and its commitment…

4 weeks ago
Starburst Named a Leader & Fast Mover in 2025 GigaOm Radar for Data Lakes & LakehousesStarburst Named a Leader & Fast Mover in 2025 GigaOm Radar for Data Lakes & Lakehouses

Starburst Named a Leader & Fast Mover in 2025 GigaOm Radar for Data Lakes & Lakehouses

BOSTON, June 18, 2025 /PRNewswire/ -- Starburst, the data platform for apps and AI, today announced it has been recognized…

4 weeks ago